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rEsuMo
os danos biológicos causados pelo uso de substâncias psicoactivas ilegais podem resultar não só das substâncias 
ilegais por si só, mas também da presença de substâncias que os traficantes lhes adicionam no sentido de aumentar 
o volume final de droga (substâncias de corte). o objectivo central do presente estudo consistiu na análise de subs-
tâncias psicoactivas ilegais e dos seus contaminantes/adulterantes, pela conjugação de esforços entre cHecK-in/
ApDes e o instituto nacional de medicina legal do porto. esta colaboração permitiu comparar dados portugueses 
com os dados gerados pelo projecto energy control em espanha, que se tem dedicado desde há mais de 10 anos à 
redução de riscos.
PALAVRAS-ChAVE: Análise química; cromatografia em camada fina; substâncias psicoativas; redução de danos; speed; 
cristal; cocaína.
abstraCt
the biological damages caused by the use of illicit psychoactive substances can result not only from the illegal 
substances themselves, but can also be due to substances that dealers had to the mixtures in order to increase the 
overall volume of drug (cutting substances). the central aim of the present study was analysing illegal psychoactive 
substances and their contaminants/adulterants, through the conjugation of efforts by cHecK-in/ApDes and instituto 
nacional de medicina legal do porto. this cooperation allowed the comparison of portuguese data with the data that 
were collected in spain by energy control, a project that has been working in risk reduction for the past 10 years. 
KEy-WORDS: chemical analysis; thin layer chromatography; psychoactive substances; damage reduction; speed; crys-
tal; cocaine.
210 1. introduction
since a decade ago, we witnessed an exponential growth of the use of recreational and illegal psycho-
active substances. this increase has special significance among youngters, in which it was possible to 
systematically observe an increase in the consumption of drugs such as speed, crystal, ecstasy and co-
caine. the increase in the use of these drugs lead to an exacerbated demand in the illegal market, which 
was an excellent opportunity of profit for dealers and smugglers. Additionally, dealers found a way to 
increase even more their profit margins, by adding other substances (adulterants) to the intoxicating 
mixtures, through the denominated cutting of the initial illicit substance. bearing this purpose in mind, 
several adulterants have been found, such as pharmaceuticals, salts, sugars, solvents, portions of dry 
fruits, ashes, glass, silica and plastics. 
the scientific core of the present study is the possibility of giving accurate scientific information to con-
sumers of illegal substances regarding the use of adulterants incorporated into the intoxicating mix-
tures. With this information, consumers may them decide about the consumption of substances that 
can pose more serious risks to their health than the intoxicating substance that they intend to use. this 
approach is inserted in a policy of damage reduction, which was recently implemented in portugal. Ac-
cording to this philosophy, the most effective process is to inform the usual consumer of illicit drugs with 
the objective of giving information about the risks inherent to his/her behaviour and to the possible 
toxicity of adulterants added to the intoxicating mixture. After a positive identification of adulterants in 
the intoxicating mixtures, the consumer is informed of their toxic effects, and is free to choose if he/she 
intends to use the recreational substances. 
the results published in the present study result from the free cooperation of consumers of illegal sub-
stances that came to the offices of Check-in project (portugal; responsibility of Agência piaget para o 
Desenvolvimento, ApDes) or Energy Control project (spain) to analyse the mixtures that they intended to 
consume. in general terms, the procedures adopted by the project energy control involved an immedi-
ate analysis of the samples, while the portuguese check-in project only performed a simple colorimetric 
assay, with marquis reagent, which indicated the presence of several substances. After this initial screen-
ing procedure, samples were analysed by thin layer chromatography (tlc). 
the present study involved a sequence of steps, in which the first was the use of the generally described 
methodology and processing of samples, in order to assess the presence or absence of contaminants. 
the second step was a generic discussion of the obtained results, for a comparison between the here 
generated data and those already available for samples collected in the iberian peninsula, for the criti-
cal evaluation of the potential for the exertion of toxic effects by adulterants. Finally, the third step was 
dedicated to the analysis of the differences between the two realities, concerning the portuguese and 
the spanish scenarios of adulteration of recreational drugs. 
2. material and metHods
2.1. saMplINg
users of recreational drugs voluntarily gave us access to samples of substances, for analysis. offices of 
the Check-in project were installed in youth and summer festivals and rave parties, during 2006 and 2007, 
and the users of these substances were invited to perform a simple and free test to the drugs that they 
possessed. 
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one of the main purposes of check-in project is the possibility of giving results concerning the adul-
terants present in samples of illegal substances to consumers, in a real time scenario. this approach 
involved the analysis of the obtained samples with the colorimetric test, in which reagent of marquis 
was added. in a few seconds, samples containing mDmA and amphetaminic derivatives were coloured. 
the coloured spots after adding marquis reagent can identify mDmA or mDA (purple to black), ampheta-
mine or methamphetamine (orange to brown), 4-bromo-2,5-dimethoxyphenethylamine (2c-b; orange 
to green), and dextromethorphan (Dxm; gray to black). For the identification of indolamines (lsD, fungal 
derivatives, foxy, 4-ac-diptidolamins and others) and several phenilethylamines (2ct2, 2cb, 2ci, Dob, 
Dom and others), we added to each spot a drop of pimethylaminobenzaldehyde 5% (p-DmAb) reagent. 
if observed under ultraviolet light, the different substances assumed different colours. For instance, psi-
locybin turned reddish-purple then faded to violet, whereas psilocin yielded a strong blue color, which 
faded to violet. in the case of lsD, the addition of this reagent caused a deep purple coloration (national 
institute of justice, 2000).
2.3. CHroMatograpHIC assays
For the detection/identification of drugs in the samples, we followed a protocol of preliminary prepara-
tion. the preparation of samples involved the use of different amounts of sample, depending on the 
substance to be tested. if we expected to analyse samples containing residues of cocaine, we used ap-
proximately 1.0 g of sample; if other substances were expected to be found, we sampled an amount of 
4.0 g. to these amounts of samples, a small portion of methanol was added, and this mixture was stirred 
until total dissolution. the methodology used for the determination of the presence of adulterants was 
tlc – thin layer chromatoraphy. this technique is used to separate pure components in a mixture. the 
separation of the compounds is due to the difference of adhesion forces between the molecules of the 
components to a mobile phase (usually a solvent, or a mixture of solvents - elluent) and to a stationary 
phase (the thin layer, frequently made of silica). this difference can be shown through a higher or lower 
proportion of drag of each individual component along the stationery phase, allowing its separation 
and identification. the use of this methodology during the present work involved the preparation of 
cuvettes for the tlc, in which strips of absorbent paper were introduced in spectrophotometry cuvettes 
with distinct sizes. the solvent (elluent) employed for the separation was composed by a mixture of 
methanol and ammonia, in a final proportion of 29.25ml:0.75ml. elluition of samples was allowed for 
30 minutes, in a closed environment saturated with vapours of the elluent mixture. the preparation of 
the silica layer was performed in order to obtain a chromatofoil, with a defined number of samples and 
standard solutions. standard solutions were transferred to the silica layer, through pippeting a volume 
of 3 μl of each standard solution. After adding each standard solution to the silica layer, the solvent was 
evaporated and the chromatofoil was observed in a revelation chamber with ultraviolet light, in order to 
assure that the applied amount of sample/standard solutions was adequate. if the transferred amounts 
were adequate, one can observe dark spots in the site of application; if the amount was insufficient, we 
should increase the amount by 1 μl, until reaching a satisfactory amount. After elluition, the solvent was 
evaporated and dried. revelation and visualization of the chromatofoil was done by inserting it into a 
revelation chamber with iodine crystals, and the comparison of the spots resulting from samples with 
those resulting from standard solutions.  
212 3. results
the work developed by the Check-In project from ApDes allowed analysing, in situ, a total of 15 samples, 
from which 10 were pills, and 5 were allegedly cocaine samples. From these two types of samples, it was 
possible to identify a total number of 9 different substances (including mDmA; figure 1) used to formula-
te pills, and cocaine samples were composed by 6 distinct products, including cocaine (figure 2). 
figure 1. results obtained after analysis of pills (n=10)
figure 2. results obtained after analysis of cocaine (n=5)
results obtained during the Energy Control project are depicted in figures 3, 4, 5 and 6, and illustrate the 
adulteration of speed, cocaine, crystal and pills samples, respectively, in spain, also during 2006 and 2007. 
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figure 3. results obtained after the analysis of speed samples in spain, 
by Project Energy Control during 2006 and 2007 (n=19).
figure 4. results obtained after the analysis of cocaine samples in spain,
by Project Energy Control during 2006 and 2007 (n=36).
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figure 5. results obtained after the analysis of crystal samples in spain,
by Project Energy Control during 2006 and 2007 (n=32).
figure 6. results obtained after the analysis of pills samples in spain, 
by Project Energy Control during 2006 and 2007 (n=42).
2154. discussion
4.1. Crystal aND spEED
the size of the global sampled substances in spain, during the period of 2006 and 2007, was much 
larger than the samples analysed in portugal, during the same period; consequently, all comparisons 
may be biased and may not reflect a complete assessment of the portuguese scenario. However, and 
after the observation of the compiled data from the iberian peninsula during 2006 and 2007, the general 
conclusion pointed to a marked similarity between the adulterants found in both countries (portugal 
and spain). However, caffeine is the most common adulterant found in crystal and speed samples. caf-
feine is a central nervous system stimulant, depending on its ability to reduce adenosine transmission 
in the brain (Fisone et al, 2004). other studies point to the involvement of different pathways that may 
be triggered by caffeine, as a central nervous stimulant. murphy et al. (2004) observed that systemically 
administered caffeine was capable of activating orexin neurons (which play a critical role in arousal) 
over non-orexin neurons. the same study showed that this compound might also be responsible by 
increased locomotion activity after acute exposure. Furthermore, caffeine can have a pronounced ef-
fect on metabolism, as shown by Haller et al (2004): its us was responsible for increased systolic blood 
pressure and plasma free fatty acid and urinary epinephrine concentrations. in spite of causing these 
biological modifications, caffeine may be used as an adulterant of illegal mixtures since users misinter-
pret its energizing properties, believing that these effects are the desired consequences of the use of the 
illegal psychoactive substances. An average of 53% of all samples of speed and crystal contained caffeine 
as adulterant; according to the sensitivity of the consumer, and to the concentration of caffeine present 
in the intoxicating mixture, we can anticipate that users may suffer potential health risks. the study by 
Haller et al. (2004) showed that an association of caffeine and another stimulant (such as ephedrine) can 
result in severe physiological modifications, such as increased systolic blood pressure and heart rate, and 
raised fasting glucose, insulin, free fatty acid, and lactate concentrations. these modifications, along with 
the impairment of specific neuronal functions, may present an additional risk to consumers of illegal 
drugs contaminated with adulterants such as the one here found.
4.2. CoCaINE
the adulteration of cocaine samples is a common issue among the illegal drug markets around the 
globe. King (1999) showed that the mean degree of purity of cocaine samples in the united Kingdom 
reached only 51%. spanish cocaine samples were usually adulterated with caffeine, in a percentage 
of about 69%; in portugal, this percentage was generally much higher, reaching 75%. these data lead 
us to the conclusion that caffeine is again a major adulterant of cocaine samples, and was present in 
the majority of analysed samples. 16% of all cocaine samples in spain were adulterated with another 
compound, lidocaine, which was also observed in portugal. Again the level of adulteration of cocaine in 
portugal was much higher, since 75% of cocaine samples contained lidocaine. this pattern of adultera-
tion is not exclusive of the portuguese reality; in fact, brazilian cocaine samples, tested for the presence 
of adulterants, showed similar results, since adulteration of cocaine with caffeine and lidocaine was also 
common (bernardo et al, 2003). Fucci and De giovanni (1998) screened samples of cocaine sold in the il-
legal market of the streets of rome (italy), and also concluded that caffeine and lidocaine were common 
adulterants. lidocaine is a local anaesthetic that has been held responsible for cardiotoxic and neuroto-
xic adverse events, as described by marra et al (2006) and by takahashi et al (2006). the direct contact of 
lidocaine with the eye can also result in lidocaine toxicity, as shown by Doat et al (2006). the oral intake 
of lidocaine-containing paediatric preparations was the causative agent for a toxic syndrome descri-
bed by Yamashita et al (2002). our samples of cocaine were also adulterated with a third substance, 
216 the analgesic/antipyretic paracetamol (acetaminophen). this is a well-known toxic compound, which 
in high doses (well above the therapeutic dosage) is frequently fatal (Davies, 2007). this pharmaceutical 
compound is the commonest cause of fulminant hepatic failure in most western countries (mcgregor et 
al, 2003); its use, as and adulterant of cocaine, may result in fatal intoxication, since cocaine is frequently 
used in high amounts during the events in which sampling took place. 
4.3. pIlls
the number of adulterants found in pills is extremely high. Among the most common adulterants, one 
can find piperazine, which is a pharmaceutical drug used as antiparasitic (boonmars et al, 2005). this 
drug has also been used by consumers of illegal substances (namely mDmA) since they mimic the effect 
of mDmA in the brain (sheridan et al, 2007; staack, 2007; baumann et al, 2005). However, several deri-
vatives of this substance may also exert stimulant or psychedelic effect, since they can act directly on 
the central nervous system (matsumoto et al, 2007; sadashiva et al, 2006). this chemical is highly toxic 
for the liver and kidneys, and its use may result in severe failure of these organs, and consequent death. 
several other compounds were added to the tested samples, such as the anti-inflammatory drug oxi-
fenbutazon, nicotinamide (vitamin b3), and codeine. codeine is an opioid, and is added to cough syrups; 
its use is not limited to therapeutics, since drugs addicted individuals use it simultaneously with cocaine 
and crack for abuse/recreational purposes (peters et al, 2007). several samples were contaminated by 
scopolamine, an hallucinogenic substance, found in plants of the Solanaceae family, which interferes 
with cholinergic function in the central nervous system, resulting in impaired behavioral performance, 
and, in the hippocampus, disrupted conditioned stimulus-evoked field potential, high frequency shift 
in field activity, and paired presentation-induced hyperexcitability (múnera et al, 2000). scopolamine is 
also an antispasmodic, used in peptic, duodenal and colic ulcers, and also in motion sickness (nachum 
et al, 2006). in spite of its therapeutic use, this is a highly toxic compound, which must be used in small 
amounts, since it may cause delirium, paralysis, coma or even death. its long-term use can lead to serious 
metabolic disturbances, as shown by piva et al (2007); this study assessed the effects of prolonged expo-
sure of pigs to scopolamine, and the authors observed gastro-intestinal alterations, where the mucous 
membrane showed lymphocytic infiltration and a loss of epithelium; villi were necrotic and replaced by 
dystrophic regeneration. several samples were tested and revealed that another adulterant was ephedri-
ne, which is a simpaticomimetic stimulant substance (Haller et al, 2004). this compound has been used 
in several pharmaceutical preparations to fight overweight, but has been identified as a causative agent 
for strong dependence (Arnold and Yager, 2007; miller and Waite, 2003). loratadine was also found in 
the tested samples, and this is an anti-histaminic drug that acts through the blockade of H1 (histamine) 
receptors. the sweetener aspartame was found among the identified adulterants, and may be used in 
order to give the convenient consistency to the manufactured pills. several other chemicals were found, 
but it was not possible to perform a positive identification. However, we have indications that, similarly 
to what was found in other samples (results not shown), these adulterants may be other psycho-active 
compounds, dry and powdered fruits, silica, salts, sugars and other organic compounds.
5. conclusions
the nature of the adulteration can be partial, when a single substance or a mixture of substances was 
added to the formulation, but one can still detect the presence of the initial illegal substance; however, 
it can also be total, when not event the desired substance can be found in the mixture, and the formu-
lation is only composed by adulterants. After the attainment of the proposed objectives, we can assume 
that 100% of all portuguese samples tested were adulterated, a scenario that was not observed in spain. 
217in fact, the percentage of tested spanish samples that was found adulterated was much lower, and a 
percentage comprised between 42 to 58% of samples from this country may be considered pure. these 
facts lead us to the conclusion that, in spite of the extremely small number of tested samples, the use of 
recreational drugs is far less subjected to adulteration in spain. this consideration may be partly explai-
ned due to the existence, in spain, of a risk reduction policy for more than 15 years, through the contri-
bution of projects such as Energy Control. the recent adoption of similar measures in portugal, that took 
place only five years ago, can also be a valuable contribution for a much-needed change concerning 
this issue. one of the most important factors to consider in the near future is the broadening and en-
largement of the sampling universe, in order to allow the identification of more contaminants, and also 
to permit a larger number of samples being analysed. these two complimentary trends will certainly 
contribute for a more comprehensive and coherent service to consumers of these types of substances, 
always bearing in mind the inherent philosophy or risk reduction.
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